Cargando…

Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities

INTRODUCTION: The World Health Organization (WHO) advocates the use of reliance practices to enable national regulatory authorities (NRAs) to improve patients’ access to medicines. This study considered whether reliance review translates into swifter medicine authorization. METHODS: Abridged review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danks, Lorraine, Semete-Makokotlela, Boitumelo, Otwombe, Kennedy, Parag, Yashmika, Walker, Stuart, Salek, Sam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626996/ https://www.ncbi.nlm.nih.gov/pubmed/37937144 http://dx.doi.org/10.3389/fmed.2023.1265058

Ejemplares similares

South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access
por: Keyter, Andrea, et al.
Publicado: (2021)

A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency
por: Keyter, Andrea, et al.
Publicado: (2020)

The South African Regulatory System: Past, Present, and Future
por: Keyter, Andrea, et al.
Publicado: (2018)

Implementation of a Framework for an Abridged Review Using Good Reliance Practices: Optimising the Medicine Regulatory Review Process in South Africa
por: Keyter, Andrea, et al.
Publicado: (2020)

Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities
por: McAuslane, Neil, et al.
Publicado: (2023)

National medicines regulatory authorities financial sustainability in the East African Community
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2020)

Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa
por: Semete‐Makokotlela, Boitumelo, et al.
Publicado: (2021)

The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA)
por: Moeti, Lerato, et al.
Publicado: (2023)

Evaluation of the Food and Drugs Authority, Ghana Regulatory Review Process: Challenges and Opportunities
por: Owusu-Asante, Mercy, et al.
Publicado: (2022)

Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022)

Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America
por: van der Zee, Ivar T., et al.
Publicado: (2022)

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry
por: Owusu-Asante, Mercy, et al.
Publicado: (2023)

The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System
por: Keyter, Andrea, et al.
Publicado: (2018)

Common deficiencies found in generic Finished Pharmaceutical Product (FPP) applications submitted for registration to the South African Health Products Regulatory Authority (SAHPRA)
por: Moeti, Lerato, et al.
Publicado: (2022)

Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines
por: Keyter, Andrea, et al.
Publicado: (2019)

Making the investment case for national regulatory authorities
por: Twesigye, Gloria, et al.
Publicado: (2021)

Media Generation and Pharmacy Regulatory Authority Awareness
por: Boyle, Todd A., et al.
Publicado: (2022)

Regulatory reliance for convergence and harmonisation in the medical device space in Asia-Pacific
por: Xu, Ming, et al.
Publicado: (2022)

Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities
por: Sithole, Tariro, et al.
Publicado: (2021)

Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
por: Shi, Junnan, et al.
Publicado: (2023)

Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
por: Durán, Carlos E., et al.
Publicado: (2021)

The African Health Profession Regulatory Collaborative for Nurses and Midwives
por: McCarthy, Carey F, et al.
Publicado: (2012)

Quality Decision-Making Practices in Pharmaceutical Companies and Regulatory Authorities: Current and Proposed Approaches to Its Documentation
por: Bujar, Magdalena, et al.
Publicado: (2020)

Industrial perceptions of medicines regulatory harmonization in the East African Community
por: Dansie, Live Storehagen, et al.
Publicado: (2019)

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
por: Ncube, Bakani Mark, et al.
Publicado: (2021)

Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents
por: Leong Wai Yeen, James, et al.
Publicado: (2014)

Regulatory requirements for the registration of generic medicines and format of drug dossiers: procedures in Sri Lanka in comparison with selected regulatory authorities
por: Thambavita, D., et al.
Publicado: (2018)

Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
por: Ingram, Beverly, et al.
Publicado: (2021)

The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland
por: Keyter, Andrea, et al.
Publicado: (2019)

FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines
por: Liberti, Lawrence, et al.
Publicado: (2017)

Author Correction: Joint disease-specificity at the regulatory base-pair level
por: Muthuirulan, Pushpanathan, et al.
Publicado: (2022)

Regulatory Authorities and Continuing Education Around the World: Adapting to COVID-19
por: Reid, Alison, et al.
Publicado: (2021)

Ultra-Processed: The Search of Positioning From the Food Industry Regulatory Authorities
por: Rego, Raul Amaral
Publicado: (2022)

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries
por: Owusu-Asante, Mercy, et al.
Publicado: (2022)

Author Correction: Reliance on model-based and model-free control in obesity
por: Janssen, Lieneke K., et al.
Publicado: (2021)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Liver transient elastography values in healthy South African children
por: Rose, Penelope C., et al.
Publicado: (2023)

COVID-19 vaccine development, production and regulatory oversight in African countries
por: Makenga, Geofrey, et al.
Publicado: (2022)

Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
por: Sithole, Tariro, et al.
Publicado: (2021)

Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
por: Chisholm, Orin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vogq6mcnf3fq28dp94u2uqbs1n